Industry Research Reports

Home > Reports > Medical Care > Liquid Formulations Drug Delivery- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Liquid Formulations Drug Delivery- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Medical Care

Published Date: 2025-01-13

Pages: 136 Pages

Report ld: 3503463

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Liquid Formulations Drug Delivery was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

Suspensions are defined as finely divided undissolved drugs dispersed in liquid vehicles. They can be a ready-to-use liquid suspension or a dry powder reconstitutable suspension, which is dispersed in water by the patient, a caregiver or a pharmacist. Solutions are defined as liquid preparations in which the drug and the various excipients are dissolved in the suitable solvent or aqueous system.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Liquid Formulations Drug Delivery, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Liquid Formulations Drug Delivery by region & country, by Type, and by Application.

The Liquid Formulations Drug Delivery market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liquid Formulations Drug Delivery.

MARKET SEGMENTATION

By Company

3M
Merck & Co
Crescita Therpeautics
Novartis International
Boehringer Ingelheim
Pfizer
Teva Pharmaceuticals
Bristol Myers Squibb
Lead Chemical
Purdue Pharma
Glenmark Pharmaceuticals
Galderma
Johnson & Johnson Private
GlaxoSmithKline
Bausch Health Companies
Hisamitsu Pharmaceuticals
Cipla
Bayer
Viatris

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Suspensions
Solutions

Segment by Application

Home Care Settings
Hospitals & Clinics
Burn Centers
Other Facilities

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Liquid Formulations Drug Delivery company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Liquid Formulations Drug Delivery in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Liquid Formulations Drug Delivery in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Liquid Formulations Drug Delivery Product Introduction

1.2 Global Liquid Formulations Drug Delivery Market Size Forecast (2020-2031)

1.3 Liquid Formulations Drug Delivery Market Trends & Drivers

1.3.1 Liquid Formulations Drug Delivery Industry Trends

1.3.2 Liquid Formulations Drug Delivery Market Drivers & Opportunity

1.3.3 Liquid Formulations Drug Delivery Market Challenges

1.3.4 Liquid Formulations Drug Delivery Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Liquid Formulations Drug Delivery Players Revenue Ranking (2024)

2.2 Global Liquid Formulations Drug Delivery Revenue by Company (2020-2025)

2.3 Key Companies Liquid Formulations Drug Delivery Manufacturing Base Distribution and Headquarters

2.4 Key Companies Liquid Formulations Drug Delivery Product Offered

2.5 Key Companies Time to Begin Mass Production of Liquid Formulations Drug Delivery

2.6 Liquid Formulations Drug Delivery Market Competitive Analysis

2.6.1 Liquid Formulations Drug Delivery Market Concentration Rate (2020-2025)

2.6.2 Global 5 and 10 Largest Companies by Liquid Formulations Drug Delivery Revenue in 2024

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liquid Formulations Drug Delivery as of 2024)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Suspensions

3.1.2 Solutions

3.2 Global Liquid Formulations Drug Delivery Sales Value by Type

3.2.1 Global Liquid Formulations Drug Delivery Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Liquid Formulations Drug Delivery Sales Value, by Type (2020-2031)

3.2.3 Global Liquid Formulations Drug Delivery Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Home Care Settings

4.1.2 Hospitals & Clinics

4.1.3 Burn Centers

4.1.4 Other Facilities

4.2 Global Liquid Formulations Drug Delivery Sales Value by Application

4.2.1 Global Liquid Formulations Drug Delivery Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Liquid Formulations Drug Delivery Sales Value, by Application (2020-2031)

4.2.3 Global Liquid Formulations Drug Delivery Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

5.1 Global Liquid Formulations Drug Delivery Sales Value by Region

5.1.1 Global Liquid Formulations Drug Delivery Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Liquid Formulations Drug Delivery Sales Value by Region (2020-2025)

5.1.3 Global Liquid Formulations Drug Delivery Sales Value by Region (2026-2031)

5.1.4 Global Liquid Formulations Drug Delivery Sales Value by Region (%), (2020-2031)

5.2 North America

5.2.1 North America Liquid Formulations Drug Delivery Sales Value, 2020-2031

5.2.2 North America Liquid Formulations Drug Delivery Sales Value by Country (%), 2024 VS 2031

5.3 Europe

5.3.1 Europe Liquid Formulations Drug Delivery Sales Value, 2020-2031

5.3.2 Europe Liquid Formulations Drug Delivery Sales Value by Country (%), 2024 VS 2031

5.4 Asia Pacific

5.4.1 Asia Pacific Liquid Formulations Drug Delivery Sales Value, 2020-2031

5.4.2 Asia Pacific Liquid Formulations Drug Delivery Sales Value by Region (%), 2024 VS 2031

5.5 South America

5.5.1 South America Liquid Formulations Drug Delivery Sales Value, 2020-2031

5.5.2 South America Liquid Formulations Drug Delivery Sales Value by Country (%), 2024 VS 2031

5.6 Middle East & Africa

5.6.1 Middle East & Africa Liquid Formulations Drug Delivery Sales Value, 2020-2031

5.6.2 Middle East & Africa Liquid Formulations Drug Delivery Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Liquid Formulations Drug Delivery Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Liquid Formulations Drug Delivery Sales Value, 2020-2031

6.3 United States

6.3.1 United States Liquid Formulations Drug Delivery Sales Value, 2020-2031

6.3.2 United States Liquid Formulations Drug Delivery Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Liquid Formulations Drug Delivery Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Liquid Formulations Drug Delivery Sales Value, 2020-2031

6.4.2 Europe Liquid Formulations Drug Delivery Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Liquid Formulations Drug Delivery Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Liquid Formulations Drug Delivery Sales Value, 2020-2031

6.5.2 China Liquid Formulations Drug Delivery Sales Value by Type (%), 2024 VS 2031

6.5.3 China Liquid Formulations Drug Delivery Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Liquid Formulations Drug Delivery Sales Value, 2020-2031

6.6.2 Japan Liquid Formulations Drug Delivery Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Liquid Formulations Drug Delivery Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Liquid Formulations Drug Delivery Sales Value, 2020-2031

6.7.2 South Korea Liquid Formulations Drug Delivery Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Liquid Formulations Drug Delivery Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Liquid Formulations Drug Delivery Sales Value, 2020-2031

6.8.2 Southeast Asia Liquid Formulations Drug Delivery Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Liquid Formulations Drug Delivery Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Liquid Formulations Drug Delivery Sales Value, 2020-2031

6.9.2 India Liquid Formulations Drug Delivery Sales Value by Type (%), 2024 VS 2031

6.9.3 India Liquid Formulations Drug Delivery Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 3M

7.1.1 3M Profile

7.1.2 3M Main Business

7.1.3 3M Liquid Formulations Drug Delivery Products, Services and Solutions

7.1.4 3M Liquid Formulations Drug Delivery Revenue (US$ Million) & (2020-2025)

7.1.5 3M Recent Developments

7.2 Merck & Co

7.2.1 Merck & Co Profile

7.2.2 Merck & Co Main Business

7.2.3 Merck & Co Liquid Formulations Drug Delivery Products, Services and Solutions

7.2.4 Merck & Co Liquid Formulations Drug Delivery Revenue (US$ Million) & (2020-2025)

7.2.5 Merck & Co Recent Developments

7.3 Crescita Therpeautics

7.3.1 Crescita Therpeautics Profile

7.3.2 Crescita Therpeautics Main Business

7.3.3 Crescita Therpeautics Liquid Formulations Drug Delivery Products, Services and Solutions

7.3.4 Crescita Therpeautics Liquid Formulations Drug Delivery Revenue (US$ Million) & (2020-2025)

7.3.5 Crescita Therpeautics Recent Developments

7.4 Novartis International

7.4.1 Novartis International Profile

7.4.2 Novartis International Main Business

7.4.3 Novartis International Liquid Formulations Drug Delivery Products, Services and Solutions

7.4.4 Novartis International Liquid Formulations Drug Delivery Revenue (US$ Million) & (2020-2025)

7.4.5 Novartis International Recent Developments

7.5 Boehringer Ingelheim

7.5.1 Boehringer Ingelheim Profile

7.5.2 Boehringer Ingelheim Main Business

7.5.3 Boehringer Ingelheim Liquid Formulations Drug Delivery Products, Services and Solutions

7.5.4 Boehringer Ingelheim Liquid Formulations Drug Delivery Revenue (US$ Million) & (2020-2025)

7.5.5 Boehringer Ingelheim Recent Developments

7.6 Pfizer

7.6.1 Pfizer Profile

7.6.2 Pfizer Main Business

7.6.3 Pfizer Liquid Formulations Drug Delivery Products, Services and Solutions

7.6.4 Pfizer Liquid Formulations Drug Delivery Revenue (US$ Million) & (2020-2025)

7.6.5 Pfizer Recent Developments

7.7 Teva Pharmaceuticals

7.7.1 Teva Pharmaceuticals Profile

7.7.2 Teva Pharmaceuticals Main Business

7.7.3 Teva Pharmaceuticals Liquid Formulations Drug Delivery Products, Services and Solutions

7.7.4 Teva Pharmaceuticals Liquid Formulations Drug Delivery Revenue (US$ Million) & (2020-2025)

7.7.5 Teva Pharmaceuticals Recent Developments

7.8 Bristol Myers Squibb

7.8.1 Bristol Myers Squibb Profile

7.8.2 Bristol Myers Squibb Main Business

7.8.3 Bristol Myers Squibb Liquid Formulations Drug Delivery Products, Services and Solutions

7.8.4 Bristol Myers Squibb Liquid Formulations Drug Delivery Revenue (US$ Million) & (2020-2025)

7.8.5 Bristol Myers Squibb Recent Developments

7.9 Lead Chemical

7.9.1 Lead Chemical Profile

7.9.2 Lead Chemical Main Business

7.9.3 Lead Chemical Liquid Formulations Drug Delivery Products, Services and Solutions

7.9.4 Lead Chemical Liquid Formulations Drug Delivery Revenue (US$ Million) & (2020-2025)

7.9.5 Lead Chemical Recent Developments

7.10 Purdue Pharma

7.10.1 Purdue Pharma Profile

7.10.2 Purdue Pharma Main Business

7.10.3 Purdue Pharma Liquid Formulations Drug Delivery Products, Services and Solutions

7.10.4 Purdue Pharma Liquid Formulations Drug Delivery Revenue (US$ Million) & (2020-2025)

7.10.5 Purdue Pharma Recent Developments

7.11 Glenmark Pharmaceuticals

7.11.1 Glenmark Pharmaceuticals Profile

7.11.2 Glenmark Pharmaceuticals Main Business

7.11.3 Glenmark Pharmaceuticals Liquid Formulations Drug Delivery Products, Services and Solutions

7.11.4 Glenmark Pharmaceuticals Liquid Formulations Drug Delivery Revenue (US$ Million) & (2020-2025)

7.11.5 Glenmark Pharmaceuticals Recent Developments

7.12 Galderma

7.12.1 Galderma Profile

7.12.2 Galderma Main Business

7.12.3 Galderma Liquid Formulations Drug Delivery Products, Services and Solutions

7.12.4 Galderma Liquid Formulations Drug Delivery Revenue (US$ Million) & (2020-2025)

7.12.5 Galderma Recent Developments

7.13 Johnson & Johnson Private

7.13.1 Johnson & Johnson Private Profile

7.13.2 Johnson & Johnson Private Main Business

7.13.3 Johnson & Johnson Private Liquid Formulations Drug Delivery Products, Services and Solutions

7.13.4 Johnson & Johnson Private Liquid Formulations Drug Delivery Revenue (US$ Million) & (2020-2025)

7.13.5 Johnson & Johnson Private Recent Developments

7.14 GlaxoSmithKline

7.14.1 GlaxoSmithKline Profile

7.14.2 GlaxoSmithKline Main Business

7.14.3 GlaxoSmithKline Liquid Formulations Drug Delivery Products, Services and Solutions

7.14.4 GlaxoSmithKline Liquid Formulations Drug Delivery Revenue (US$ Million) & (2020-2025)

7.14.5 GlaxoSmithKline Recent Developments

7.15 Bausch Health Companies

7.15.1 Bausch Health Companies Profile

7.15.2 Bausch Health Companies Main Business

7.15.3 Bausch Health Companies Liquid Formulations Drug Delivery Products, Services and Solutions

7.15.4 Bausch Health Companies Liquid Formulations Drug Delivery Revenue (US$ Million) & (2020-2025)

7.15.5 Bausch Health Companies Recent Developments

7.16 Hisamitsu Pharmaceuticals

7.16.1 Hisamitsu Pharmaceuticals Profile

7.16.2 Hisamitsu Pharmaceuticals Main Business

7.16.3 Hisamitsu Pharmaceuticals Liquid Formulations Drug Delivery Products, Services and Solutions

7.16.4 Hisamitsu Pharmaceuticals Liquid Formulations Drug Delivery Revenue (US$ Million) & (2020-2025)

7.16.5 Hisamitsu Pharmaceuticals Recent Developments

7.17 Cipla

7.17.1 Cipla Profile

7.17.2 Cipla Main Business

7.17.3 Cipla Liquid Formulations Drug Delivery Products, Services and Solutions

7.17.4 Cipla Liquid Formulations Drug Delivery Revenue (US$ Million) & (2020-2025)

7.17.5 Cipla Recent Developments

7.18 Bayer

7.18.1 Bayer Profile

7.18.2 Bayer Main Business

7.18.3 Bayer Liquid Formulations Drug Delivery Products, Services and Solutions

7.18.4 Bayer Liquid Formulations Drug Delivery Revenue (US$ Million) & (2020-2025)

7.18.5 Bayer Recent Developments

7.19 Viatris

7.19.1 Viatris Profile

7.19.2 Viatris Main Business

7.19.3 Viatris Liquid Formulations Drug Delivery Products, Services and Solutions

7.19.4 Viatris Liquid Formulations Drug Delivery Revenue (US$ Million) & (2020-2025)

7.19.5 Viatris Recent Developments

8 Industry Chain Analysis

8.1 Liquid Formulations Drug Delivery Industrial Chain

8.2 Liquid Formulations Drug Delivery Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Liquid Formulations Drug Delivery Sales Model

8.5.2 Sales Channel

8.5.3 Liquid Formulations Drug Delivery Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Liquid Formulations Drug Delivery Market Trends

Table 2. Liquid Formulations Drug Delivery Market Drivers & Opportunity

Table 3. Liquid Formulations Drug Delivery Market Challenges

Table 4. Liquid Formulations Drug Delivery Market Restraints

Table 5. Global Liquid Formulations Drug Delivery Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Liquid Formulations Drug Delivery Revenue Market Share by Company (2020-2025)

Table 7. Key Companies Liquid Formulations Drug Delivery Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Liquid Formulations Drug Delivery Product Type

Table 9. Key Companies Time to Begin Mass Production of Liquid Formulations Drug Delivery

Table 10. Global Liquid Formulations Drug Delivery Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liquid Formulations Drug Delivery as of 2024)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Liquid Formulations Drug Delivery Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 14. Global Liquid Formulations Drug Delivery Sales Value by Type (2020-2025) & (US$ Million)

Table 15. Global Liquid Formulations Drug Delivery Sales Value by Type (2026-2031) & (US$ Million)

Table 16. Global Liquid Formulations Drug Delivery Sales Market Share in Value by Type (2020-2025)

Table 17. Global Liquid Formulations Drug Delivery Sales Market Share in Value by Type (2026-2031)

Table 18. Global Liquid Formulations Drug Delivery Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 19. Global Liquid Formulations Drug Delivery Sales Value by Application (2020-2025) & (US$ Million)

Table 20. Global Liquid Formulations Drug Delivery Sales Value by Application (2026-2031) & (US$ Million)

Table 21. Global Liquid Formulations Drug Delivery Sales Market Share in Value by Application (2020-2025)

Table 22. Global Liquid Formulations Drug Delivery Sales Market Share in Value by Application (2026-2031)

Table 23. Global Liquid Formulations Drug Delivery Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 24. Global Liquid Formulations Drug Delivery Sales Value by Region (2020-2025) & (US$ Million)

Table 25. Global Liquid Formulations Drug Delivery Sales Value by Region (2026-2031) & (US$ Million)

Table 26. Global Liquid Formulations Drug Delivery Sales Value by Region (2020-2025) & (%)

Table 27. Global Liquid Formulations Drug Delivery Sales Value by Region (2026-2031) & (%)

Table 28. Key Countries/Regions Liquid Formulations Drug Delivery Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 29. Key Countries/Regions Liquid Formulations Drug Delivery Sales Value, (2020-2025) & (US$ Million)

Table 30. Key Countries/Regions Liquid Formulations Drug Delivery Sales Value, (2026-2031) & (US$ Million)

Table 31. 3M Basic Information List

Table 32. 3M Description and Business Overview

Table 33. 3M Liquid Formulations Drug Delivery Products, Services and Solutions

Table 34. Revenue (US$ Million) in Liquid Formulations Drug Delivery Business of 3M (2020-2025)

Table 35. 3M Recent Developments

Table 36. Merck & Co Basic Information List

Table 37. Merck & Co Description and Business Overview

Table 38. Merck & Co Liquid Formulations Drug Delivery Products, Services and Solutions

Table 39. Revenue (US$ Million) in Liquid Formulations Drug Delivery Business of Merck & Co (2020-2025)

Table 40. Merck & Co Recent Developments

Table 41. Crescita Therpeautics Basic Information List

Table 42. Crescita Therpeautics Description and Business Overview

Table 43. Crescita Therpeautics Liquid Formulations Drug Delivery Products, Services and Solutions

Table 44. Revenue (US$ Million) in Liquid Formulations Drug Delivery Business of Crescita Therpeautics (2020-2025)

Table 45. Crescita Therpeautics Recent Developments

Table 46. Novartis International Basic Information List

Table 47. Novartis International Description and Business Overview

Table 48. Novartis International Liquid Formulations Drug Delivery Products, Services and Solutions

Table 49. Revenue (US$ Million) in Liquid Formulations Drug Delivery Business of Novartis International (2020-2025)

Table 50. Novartis International Recent Developments

Table 51. Boehringer Ingelheim Basic Information List

Table 52. Boehringer Ingelheim Description and Business Overview

Table 53. Boehringer Ingelheim Liquid Formulations Drug Delivery Products, Services and Solutions

Table 54. Revenue (US$ Million) in Liquid Formulations Drug Delivery Business of Boehringer Ingelheim (2020-2025)

Table 55. Boehringer Ingelheim Recent Developments

Table 56. Pfizer Basic Information List

Table 57. Pfizer Description and Business Overview

Table 58. Pfizer Liquid Formulations Drug Delivery Products, Services and Solutions

Table 59. Revenue (US$ Million) in Liquid Formulations Drug Delivery Business of Pfizer (2020-2025)

Table 60. Pfizer Recent Developments

Table 61. Teva Pharmaceuticals Basic Information List

Table 62. Teva Pharmaceuticals Description and Business Overview

Table 63. Teva Pharmaceuticals Liquid Formulations Drug Delivery Products, Services and Solutions

Table 64. Revenue (US$ Million) in Liquid Formulations Drug Delivery Business of Teva Pharmaceuticals (2020-2025)

Table 65. Teva Pharmaceuticals Recent Developments

Table 66. Bristol Myers Squibb Basic Information List

Table 67. Bristol Myers Squibb Description and Business Overview

Table 68. Bristol Myers Squibb Liquid Formulations Drug Delivery Products, Services and Solutions

Table 69. Revenue (US$ Million) in Liquid Formulations Drug Delivery Business of Bristol Myers Squibb (2020-2025)

Table 70. Bristol Myers Squibb Recent Developments

Table 71. Lead Chemical Basic Information List

Table 72. Lead Chemical Description and Business Overview

Table 73. Lead Chemical Liquid Formulations Drug Delivery Products, Services and Solutions

Table 74. Revenue (US$ Million) in Liquid Formulations Drug Delivery Business of Lead Chemical (2020-2025)

Table 75. Lead Chemical Recent Developments

Table 76. Purdue Pharma Basic Information List

Table 77. Purdue Pharma Description and Business Overview

Table 78. Purdue Pharma Liquid Formulations Drug Delivery Products, Services and Solutions

Table 79. Revenue (US$ Million) in Liquid Formulations Drug Delivery Business of Purdue Pharma (2020-2025)

Table 80. Purdue Pharma Recent Developments

Table 81. Glenmark Pharmaceuticals Basic Information List

Table 82. Glenmark Pharmaceuticals Description and Business Overview

Table 83. Glenmark Pharmaceuticals Liquid Formulations Drug Delivery Products, Services and Solutions

Table 84. Revenue (US$ Million) in Liquid Formulations Drug Delivery Business of Glenmark Pharmaceuticals (2020-2025)

Table 85. Glenmark Pharmaceuticals Recent Developments

Table 86. Galderma Basic Information List

Table 87. Galderma Description and Business Overview

Table 88. Galderma Liquid Formulations Drug Delivery Products, Services and Solutions

Table 89. Revenue (US$ Million) in Liquid Formulations Drug Delivery Business of Galderma (2020-2025)

Table 90. Galderma Recent Developments

Table 91. Johnson & Johnson Private Basic Information List

Table 92. Johnson & Johnson Private Description and Business Overview

Table 93. Johnson & Johnson Private Liquid Formulations Drug Delivery Products, Services and Solutions

Table 94. Revenue (US$ Million) in Liquid Formulations Drug Delivery Business of Johnson & Johnson Private (2020-2025)

Table 95. Johnson & Johnson Private Recent Developments

Table 96. GlaxoSmithKline Basic Information List

Table 97. GlaxoSmithKline Description and Business Overview

Table 98. GlaxoSmithKline Liquid Formulations Drug Delivery Products, Services and Solutions

Table 99. Revenue (US$ Million) in Liquid Formulations Drug Delivery Business of GlaxoSmithKline (2020-2025)

Table 100. GlaxoSmithKline Recent Developments

Table 101. Bausch Health Companies Basic Information List

Table 102. Bausch Health Companies Description and Business Overview

Table 103. Bausch Health Companies Liquid Formulations Drug Delivery Products, Services and Solutions

Table 104. Revenue (US$ Million) in Liquid Formulations Drug Delivery Business of Bausch Health Companies (2020-2025)

Table 105. Bausch Health Companies Recent Developments

Table 106. Hisamitsu Pharmaceuticals Basic Information List

Table 107. Hisamitsu Pharmaceuticals Description and Business Overview

Table 108. Hisamitsu Pharmaceuticals Liquid Formulations Drug Delivery Products, Services and Solutions

Table 109. Revenue (US$ Million) in Liquid Formulations Drug Delivery Business of Hisamitsu Pharmaceuticals (2020-2025)

Table 110. Hisamitsu Pharmaceuticals Recent Developments

Table 111. Cipla Basic Information List

Table 112. Cipla Description and Business Overview

Table 113. Cipla Liquid Formulations Drug Delivery Products, Services and Solutions

Table 114. Revenue (US$ Million) in Liquid Formulations Drug Delivery Business of Cipla (2020-2025)

Table 115. Cipla Recent Developments

Table 116. Bayer Basic Information List

Table 117. Bayer Description and Business Overview

Table 118. Bayer Liquid Formulations Drug Delivery Products, Services and Solutions

Table 119. Revenue (US$ Million) in Liquid Formulations Drug Delivery Business of Bayer (2020-2025)

Table 120. Bayer Recent Developments

Table 121. Viatris Basic Information List

Table 122. Viatris Description and Business Overview

Table 123. Viatris Liquid Formulations Drug Delivery Products, Services and Solutions

Table 124. Revenue (US$ Million) in Liquid Formulations Drug Delivery Business of Viatris (2020-2025)

Table 125. Viatris Recent Developments

Table 126. Key Raw Materials Lists

Table 127. Raw Materials Key Suppliers Lists

Table 128. Liquid Formulations Drug Delivery Downstream Customers

Table 129. Liquid Formulations Drug Delivery Distributors List

Table 130. Research Programs/Design for This Report

Table 131. Key Data Information from Secondary Sources

Table 132. Key Data Information from Primary Sources

Table 133. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Liquid Formulations Drug Delivery Product Picture

Figure 2. Global Liquid Formulations Drug Delivery Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Liquid Formulations Drug Delivery Sales Value (2020-2031) & (US$ Million)

Figure 4. Liquid Formulations Drug Delivery Report Years Considered

Figure 5. Global Liquid Formulations Drug Delivery Players Revenue Ranking (2024) & (US$ Million)

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Liquid Formulations Drug Delivery Revenue in 2024

Figure 7. Liquid Formulations Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 8. Suspensions Picture

Figure 9. Solutions Picture

Figure 10. Global Liquid Formulations Drug Delivery Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 11. Global Liquid Formulations Drug Delivery Sales Value Market Share by Type, 2024 & 2031

Figure 12. Product Picture of Home Care Settings

Figure 13. Product Picture of Hospitals & Clinics

Figure 14. Product Picture of Burn Centers

Figure 15. Product Picture of Other Facilities

Figure 16. Global Liquid Formulations Drug Delivery Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 17. Global Liquid Formulations Drug Delivery Sales Value Market Share by Application, 2024 & 2031

Figure 18. North America Liquid Formulations Drug Delivery Sales Value (2020-2031) & (US$ Million)

Figure 19. North America Liquid Formulations Drug Delivery Sales Value by Country (%), 2024 VS 2031

Figure 20. Europe Liquid Formulations Drug Delivery Sales Value, (2020-2031) & (US$ Million)

Figure 21. Europe Liquid Formulations Drug Delivery Sales Value by Country (%), 2024 VS 2031

Figure 22. Asia Pacific Liquid Formulations Drug Delivery Sales Value, (2020-2031) & (US$ Million)

Figure 23. Asia Pacific Liquid Formulations Drug Delivery Sales Value by Region (%), 2024 VS 2031

Figure 24. South America Liquid Formulations Drug Delivery Sales Value, (2020-2031) & (US$ Million)

Figure 25. South America Liquid Formulations Drug Delivery Sales Value by Country (%), 2024 VS 2031

Figure 26. Middle East & Africa Liquid Formulations Drug Delivery Sales Value, (2020-2031) & (US$ Million)

Figure 27. Middle East & Africa Liquid Formulations Drug Delivery Sales Value by Country (%), 2024 VS 2031

Figure 28. Key Countries/Regions Liquid Formulations Drug Delivery Sales Value (%), (2020-2031)

Figure 29. United States Liquid Formulations Drug Delivery Sales Value, (2020-2031) & (US$ Million)

Figure 30. United States Liquid Formulations Drug Delivery Sales Value by Type (%), 2024 VS 2031

Figure 31. United States Liquid Formulations Drug Delivery Sales Value by Application (%), 2024 VS 2031

Figure 32. Europe Liquid Formulations Drug Delivery Sales Value, (2020-2031) & (US$ Million)

Figure 33. Europe Liquid Formulations Drug Delivery Sales Value by Type (%), 2024 VS 2031

Figure 34. Europe Liquid Formulations Drug Delivery Sales Value by Application (%), 2024 VS 2031

Figure 35. China Liquid Formulations Drug Delivery Sales Value, (2020-2031) & (US$ Million)

Figure 36. China Liquid Formulations Drug Delivery Sales Value by Type (%), 2024 VS 2031

Figure 37. China Liquid Formulations Drug Delivery Sales Value by Application (%), 2024 VS 2031

Figure 38. Japan Liquid Formulations Drug Delivery Sales Value, (2020-2031) & (US$ Million)

Figure 39. Japan Liquid Formulations Drug Delivery Sales Value by Type (%), 2024 VS 2031

Figure 40. Japan Liquid Formulations Drug Delivery Sales Value by Application (%), 2024 VS 2031

Figure 41. South Korea Liquid Formulations Drug Delivery Sales Value, (2020-2031) & (US$ Million)

Figure 42. South Korea Liquid Formulations Drug Delivery Sales Value by Type (%), 2024 VS 2031

Figure 43. South Korea Liquid Formulations Drug Delivery Sales Value by Application (%), 2024 VS 2031

Figure 44. Southeast Asia Liquid Formulations Drug Delivery Sales Value, (2020-2031) & (US$ Million)

Figure 45. Southeast Asia Liquid Formulations Drug Delivery Sales Value by Type (%), 2024 VS 2031

Figure 46. Southeast Asia Liquid Formulations Drug Delivery Sales Value by Application (%), 2024 VS 2031

Figure 47. India Liquid Formulations Drug Delivery Sales Value, (2020-2031) & (US$ Million)

Figure 48. India Liquid Formulations Drug Delivery Sales Value by Type (%), 2024 VS 2031

Figure 49. India Liquid Formulations Drug Delivery Sales Value by Application (%), 2024 VS 2031

Figure 50. Liquid Formulations Drug Delivery Industrial Chain

Figure 51. Liquid Formulations Drug Delivery Manufacturing Cost Structure

Figure 52. Channels of Distribution (Direct Sales, and Distribution)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

Figure 55. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Liquid Formulations Drug Delivery market? zhanKai

The top companies in the global Liquid Formulations Drug Delivery market are 3M、Merck & Co、Crescita Therpeautics.

Related Reports

Global Liquid Formulations Drug Delivery Market Research Report 2025
The global market for Liquid Formulations Drug Delivery was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-13
Pages: 99
USD 2900.00
(Single User License)
Global Liquid Formulations Drug Delivery Market Insights, Forecast to 2030
Suspensions are defined as finely divided undissolved drugs dispersed in liquid vehicles. They can be a ready-to-use liquid suspension or a dry powder reconstitutable suspension, which is dispersed in water by the patient, a caregiver or a pharmacist. Solutions are defined as liquid preparations in which the drug and the various excipients are dissolved in the suitable solvent or aqueous system.
Published Date: 2024-04-10
Pages: 112
USD 4900.00
(Single User License)
Global Liquid Formulations Drug Delivery Market Research Report 2024
Suspensions are defined as finely divided undissolved drugs dispersed in liquid vehicles. They can be a ready-to-use liquid suspension or a dry powder reconstitutable suspension, which is dispersed in water by the patient, a caregiver or a pharmacist. Solutions are defined as liquid preparations in which the drug and the various excipients are dissolved in the suitable solvent or aqueous system.
Published Date: 2024-01-17
Pages: 91
USD 2900.00
(Single User License)

Global Liquid Formulations Drug Delivery Market Research Report 2025
The global market for Liquid Formulations Drug Delivery was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-13
Pages: 99
USD 2900.00 (Single User License)
Global Liquid Formulations Drug Delivery Market Insights, Forecast to 2030
Suspensions are defined as finely divided undissolved drugs dispersed in liquid vehicles. They can be a ready-to-use liquid suspension or a dry powder reconstitutable suspension, which is dispersed in water by the patient, a caregiver or a pharmacist. Solutions are defined as liquid preparations in which the drug and the various excipients are dissolved in the suitable solvent or aqueous system.
Published: 2024-04-10
Pages: 112
USD 4900.00 (Single User License)
Global Liquid Formulations Drug Delivery Market Research Report 2024
Suspensions are defined as finely divided undissolved drugs dispersed in liquid vehicles. They can be a ready-to-use liquid suspension or a dry powder reconstitutable suspension, which is dispersed in water by the patient, a caregiver or a pharmacist. Solutions are defined as liquid preparations in which the drug and the various excipients are dissolved in the suitable solvent or aqueous system.
Published: 2024-01-17
Pages: 91
USD 2900.00 (Single User License)